Immunodeficiency and the Risk of Death in HIV Infection
JAMAPublished 18 November 1992
A. N. Phillips
Citations59
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
In patients with HIV infection who are closely followed up, the risk of death is low before the CD4 lymphocyte count has fallen to 0.05 x 10(9)/L, a count many patients remain above up to 12 years after seroconversion.
Abstract
In patients with HIV infection who are closely followed up, the risk of death is low before the CD4 lymphocyte count has fallen to 0.05 x 10(9)/L, a count many patients remain above up to 12 years after seroconversion.
Keywords
Medicine
New England Journal of MedicineThe Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1
1,032 Citations1990John L. Fahey, Jeremy M. G. Taylor +5 more
The LancetHEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
900 Citations1989Rafael Esteban, L. Viladomiu +12 more
The frequency of hepatitis C virus infection in Spain was assessed by means of a recombinant-based immunoassay for serum anti-HCV antibodies and only 8% of homosexual men infected with human immunodeficiency virus and 6% of female contacts of drug abusers were positive.
The LancetDetection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity
565 Citations1990Jeremy A. Garson
Stored serum samples from blood donors who had been involved in three episodes of post-transfusion NANBH in 1981 also contained hepatitis C viral sequences, which seem to be a better predictor of infectivity than the presence of anti-C100 alone.
BMJSeropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort
548 Citations1988Andrew R. Moss, Peter Bacchetti +7 more
It is concluded from the observed rates and the distribution of predictive variables at three years that half of the men who were seropositive for HIV will develop AIDS by six years after the start of the study, and three quarters will developAIDS or an AIDS related condition.
New England Journal of MedicineA Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with Hemophilia
526 Citations1989James J. Goedert, Craig M. Kessler +18 more
The findings not only demonstrate that the risk of AIDS is related directly to age but also suggest that older adults are disproportionately affected during the earlier phases of HIV disease, that adolescents may have a low replication rate of HIV, and that children and adolescents may tolerate severe immunodeficiency better because they have fewer other infections or because of some unmeasured, age-dependent cofactor or immune alteration in the later phase of HIV Disease.
New England Journal of MedicinePredictors of the Acquired Immunodeficiency Syndrome Developing in a Cohort of Seropositive Homosexual Men
518 Citations1987B. Frank Polk, Robin Fox +6 more
In a cohort of 1835 homosexual men who were seropositive for human immunodeficiency virus (HIV) on entry into a prospective study, the acquired immunodficiency syndrome (AIDS) developed in 59 during a median follow-up of 15 months.
Annals of Internal MedicineCD4 Counts as Predictors of Opportunistic Pneumonias in Human Immunodeficiency Virus (HIV) Infection
500 Citations1989Henry Masur, Frederick P. Ognibene +16 more
Pneumocystis pneumonia, cytomegalovirus pneumonia, and pulmonary infection caused by C. neoformans or M. avium-intracellulare are unlikely to occur in HIV-infected patients who have had a CD4 count above 0.200 to 0.250 X 10(9) cells/L or aCD4 percent above 20% to 25% in the 60 days before pulmonary evaluation.
Annals of Internal MedicineNatural History of Human Immunodeficiency Virus Infections in Hemophiliacs: Effects of T-Cell Subsets, Platelet Counts, and Age
305 Citations1987M. Elaine Eyster, Mitchell H. Gail +3 more
Serial T-cell subsets and platelet counts were determined in a cohort of 84 hemophiliacs in whom time of seroconversion for human immunodeficiency virus (HIV) antibody could be ascertained, suggesting that decreasing or very low T4 cell counts have predictive value for the development of AIDS.
The LancetSerial CD4 lymphocyte counts and development of AIDS
296 Citations1991ChristineA. Lee, PeterB.A. Kernoff +5 more
The results suggest that differences in the time at which patients with HIV will progress to AIDS can largely be explained by differences in rates of decline of CD4 lymphocyte counts.
PubMedPatterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS.
237 Citations1989William Lang, H. A. Perkins +4 more
Among AIDS-free prevalent seropositives, CD4 levels fell steadily over 36 months of observation, while CD8 lymphocyte counts rose dramatically at seroconversion, and among men who developed AIDS, CD8 cell levels rose slowly.
Clinical & Experimental ImmunologyLaboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
228 Citations1992M Bofill, George Janossy +7 more
In heterosexual controls, people with various clotting disorders but without lymphocyte abnormalities as well as seronegative homosexual men as the appropriate controls for the HIV‐1‐infected groups, the stability of CD4% and CD8% values was demonstrated throughout life, and in children CD4 values < 25% could be regarded as abnormal.
The Journal of ImmunologyThe cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage.
183 Citations1987Dario Campana, Jeffrey S. Thompson +3 more
The cCD3, TdT combination provides a very sensitive assay for residual T-ALL blasts outside the normal thymus, including cases that concomitantly express CD7 and myeloid antigens.
The American Journal of MedicineCorrelation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome
171 Citations1985H. Clifford Lane, Henry Masur +7 more
Those patients who present with opportunistic infections as their initial clinical manifestation of AIDS may represent a subgroup with a more severe immunologic derangement prior to clinical diagnosis, and this finding is of importance in attempts to understand the pathogenesis of this syndrome.
Annals of Internal MedicineCD4 Count and the Risk for Death in Patients Infected with HIV Receiving Antiretroviral Therapy
158 Citations1991Robert Yarchoan, David Venzon +6 more
In a carefully followed cohort of patients treated with zidovudine-based antiretroviral therapy, nearly all deaths occurred in patients with fewer than 50 CD4 cells/mm3, which may have implications in the monitoring of patients with AIDS and in the use of CD4 count as a clinical trials end point for the antifiltration of HIV infection.
BMJHepatitis C virus: evidence for sexual transmission.
149 Citations1991Richard S. Tedder, Richard Gilson +6 more
The study provides strong evidence for the sexual transmission of hepatitis C virus in patients attending a genitourinary medicine clinic, as evidence for sexual transmission.
PubMedAn immunohistological approach to persistent lymphadenopathy and its relevance to AIDS.
105 Citations1985George Janossy, A J Pinching +8 more
Eleven patients with PGL have been studied by immunohistology using monoclonal antibodies to dendritic reticulum cells of the germinal centre, T and B lymphocyte subsets, plasma cells and factor VIII, as an endothelial marker, indicating that T4+ cells may preferentially settle in tissues at the time of T4 lymphopenia.
BMJProgression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone.
101 Citations1990Rainer Weber, Bruno Ledergerber +3 more
Stopping the misuse of injected drugs slows the progression of HIV disease in infected subjects and drug treatment programmes are effective in secondary prevention of HIV associated morbidity.
Annals of Internal MedicinePredictive Markers for the Acquired Immunodeficiency Syndrome (AIDS) in Hemophiliacs: Persistence of p24 Antigen and Low T4 Cell Count
81 Citations1989Eyster Me, Ballard Jo +3 more
Findings have important implications regarding prognosis, counseling, and the planning of clinical trials as p24 antigenemia or low T4 counts are strong predictors of AIDS.
British Journal of HaematologyThe natural history of human immunodeficiency virus infection in a haemophilic cohort
80 Citations1989Christine A. Lee, Andrew Phillips +5 more
The decline of the T4 lymphocyte count to 0.2 × 109/1 may be an appropriate additional end‐point for the assessment of new treatments for asymptomatic patients infected with HIV.
BMJProgression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.
67 Citations1991C A Lee, Andrew Phillips +4 more
Treatment seems to be reducing the progression of HIV disease in this haemophilic cohort, and the estimated rate of progression to AIDS was 42% at 11 years from seroconversion.
The Journal of Infectious DiseasesSummary of the Workshop on Future Directions in Discovery and Development of Therapeutic Agents for Opportunistic Infections Associated with AIDS
37 Citations1991Barbara E. Laughon, H.S. Allaudeen +10 more
This work presents a meta-analyses of the prophylactic and non-proliferation of Clostridium difficile infection during the first trimester of pregnancy and shows clear trends in prognosis and in the number of cases treated with antibiotics and in some cases with anti-inflammatory drugs.
PubMedThe cumulative risk of AIDS as the CD4 lymphocyte count declines.
36 Citations1992A. N. Phillips, C. A. Lee +3 more
The Kaplan-Meier (product-limit) estimates, of the proportion of individuals developing AIDS before reaching a given low CD4 lymphocyte count, may be useful for determining when prophylactic treatment should begin.